Literature DB >> 31127032

USP19 Inhibits TNF-α- and IL-1β-Triggered NF-κB Activation by Deubiquitinating TAK1.

Cao-Qi Lei1,2,3, Xin Wu4,2,3, Xuan Zhong4,2,3, Lu Jiang4,2,3, Bo Zhong4,3, Hong-Bing Shu1,2,3.   

Abstract

The dynamic regulations of ubiquitination and deubiquitination play important roles in TGF-β-activated kinase 1 (TAK1)-mediated NF-κB activation, which regulates various physiological and pathological events. We identified ubiquitin-specific protease (USP)19 as a negative regulator of TNF-α- and IL-1β-triggered NF-κB activation by deubiquitinating TAK1. Overexpression of USP19 but not its enzymatic inactive mutant inhibited TNF-α- and IL-1β-triggered NF-κB activation and transcription of downstream genes, whereas USP19 deficiency had the opposite effects. Usp19-/- mice produced higher levels of inflammatory cytokines and were more susceptible to TNF-α- and IL-1β-triggered septicemia death compared with their wild-type littermates. Mechanistically, USP19 interacted with TAK1 in a TNF-α- or IL-1β-dependent manner and specifically deconjugated K63- and K27-linked polyubiquitin chains from TAK1, leading to the impairment of TAK1 activity and the disruption of the TAK1-TAB2/3 complex. Our findings provide new insights to the complicated molecular mechanisms of the attenuation of the inflammatory response.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31127032     DOI: 10.4049/jimmunol.1900083

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.

Authors:  Jingyue Jia; Bhawana Bissa; Lukas Brecht; Lee Allers; Seong Won Choi; Yuexi Gu; Mark Zbinden; Mark R Burge; Graham Timmins; Kenneth Hallows; Christian Behrends; Vojo Deretic
Journal:  Mol Cell       Date:  2020-01-28       Impact factor: 17.970

2.  TRIM47 activates NF-κB signaling via PKC-ε/PKD3 stabilization and contributes to endocrine therapy resistance in breast cancer.

Authors:  Kotaro Azuma; Kazuhiro Ikeda; Takashi Suzuki; Kenjiro Aogi; Kuniko Horie-Inoue; Satoshi Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-31       Impact factor: 11.205

3.  Tankyrases inhibit innate antiviral response by PARylating VISA/MAVS and priming it for RNF146-mediated ubiquitination and degradation.

Authors:  Yan-Ran Xu; Meng-Ling Shi; Yu Zhang; Na Kong; Cong Wang; Yi-Feng Xiao; Shi-Shen Du; Qi-Yun Zhu; Cao-Qi Lei
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-21       Impact factor: 12.779

Review 4.  Emerging Role of Ubiquitin-Specific Protease 19 in Oncogenesis and Cancer Development.

Authors:  Fabiana Alejandra Rossi; Mario Rossi
Journal:  Front Cell Dev Biol       Date:  2022-05-12

5.  C1QBP regulates apoptosis of renal cell carcinoma via modulating xanthine dehydrogenase (XDH) mediated ROS generation.

Authors:  Yiting Wang; Shuang Liu; Shaoping Tian; Runxuan Du; Tianyu Lin; Xuesong Xiao; Rui Wang; Ruibing Chen; Hua Geng; Saravanan Subramanian; Yuanjie Niu; Yong Wang; Dan Yue
Journal:  Int J Med Sci       Date:  2022-05-09       Impact factor: 3.642

6.  TRIM26 positively regulates the inflammatory immune response through K11-linked ubiquitination of TAB1.

Authors:  Jian Zhao; Baoshan Cai; Zhugui Shao; Lei Zhang; Yi Zheng; Chunhong Ma; Fan Yi; Bingyu Liu; Chengjiang Gao
Journal:  Cell Death Differ       Date:  2021-05-20       Impact factor: 15.828

7.  Silencing TAK1 reduces MAPKs-MMP2/9 expression to reduce inflammation-driven neurohistological disruption post spinal cord injury.

Authors:  Shuai Jiang; Yandan Wu; Shunjie Wu; Suhui Ye; Renyi Kong; Jie Chang; Mingjie Xia; Junping Bao; Xin Peng; Xin Hong; Zhanyang Qian; Haijun Li
Journal:  Cell Death Discov       Date:  2021-05-08

Review 8.  Contributions of Ubiquitin and Ubiquitination to Flaviviral Antagonism of Type I IFN.

Authors:  Erika Hay-McCullough; Juliet Morrison
Journal:  Viruses       Date:  2021-04-27       Impact factor: 5.048

Review 9.  Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors.

Authors:  Shiyao Chen; Yunqi Liu; Huchen Zhou
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 10.  Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential.

Authors:  Jun-Nan Guo; Bai-Rong Xia; Shen-Hui Deng; Chang Yang; Ya-Nan Pi; Bin-Bin Cui; Wei-Lin Jin
Journal:  Front Cell Dev Biol       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.